The U.S. Department of Veterans Affairs Awards Contract to Evofem Biosciences for Phexxi®
SAN DIEGO, Dec. 3, 2020 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that the U.S. Department of Veterans Affairs (VA) has awarded the Company a contract for the purchase of Phexxi® (lactic acid, citric acid and potassium bitartrate) for a five-year period…
Comments Off on The U.S. Department of Veterans Affairs Awards Contract to Evofem Biosciences for Phexxi®